Peptide record

TPDB10652

Ple Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10652
Ple
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 SATPdb dbACP Antifungipept CAFPdb i2APP APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 25-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GWGSFFKKAAHVGKHVGKAALTHYL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C129H192N36O29
RNDCEQIMP
AGK
2711.17
10.64
7
0
12
+4
0.20
-0.068
70.40
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
6990
2.58
3
Residue Composition
number
4
A
0
R
0
N
0
D
0
C
0
E
0
Q
4
G
3
H
0
I
2
L
4
K
0
M
2
F
0
P
1
S
1
T
1
W
1
Y
2
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 4 H: 3 I: 0 L: 2 K: 4 M: 0 F: 2 P: 0 S: 1 T: 1 W: 1 Y: 1 V: 2
Chemical Descriptors
25 reviewed residue count
C129H192N36O29 sequence-only estimate (linear, free termini)
2711.17 sequence-only estimate (linear, free termini)
10.64 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
0.20 sequence-only estimate (linear, free termini)
-0.068 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Linear Activity
Free Activity
Antimicrobial Activity
Pleuronectes americanus Activity
Evidence Records 85 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2 µM

Target

A. salmonicida 99-1

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I o
Evidence 2 Activity

Activity

MIC
Antibacterial
2 µM

Target

A. salmonicida 97-4

Source & Reference

dbAMP DRAMP

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aerugin
Evidence 3 Activity

Activity

MIC
Antibacterial
2-17.7 µM

Target

S. enterica serovar Typhimurium MS7953s or 14028s or I or II

Source & Reference

dbAMP DRAMP

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM),
Evidence 4 Activity

Activity

MIC
Antibacterial
4-8 µM

Target

Pseudomonas aeruginosa K799 or Z61

Source & Reference

dbAMP DRAMP

Other

(MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicil
Evidence 5 Activity

Activity

MIC
Antibacterial
2-4 µM

Target

Escherichia coli CGSC4908 or UB1005 or DC2

Source & Reference

dbAMP DRAMP

Other

ium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM),
Evidence 6 Activity

Activity

MIC
Antibacterial
8 µM

Target

Staphylococcus epidermidis C621

Source & Reference

dbAMP DRAMP

Other

, P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Al
Evidence 7 Activity

Activity

MIC
Antibacterial
8 µM

Target

Staphylococcus aureus C623 or MRSA

Source & Reference

dbAMP DRAMP

Other

4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonici
Evidence 8 Activity

Activity

MIC
Antibacterial
8 µM

Target

Candida albicans C627

Source & Reference

dbAMP DRAMP

Other

S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aerugino
Evidence 9 Activity

Activity

MIC
Antibacterial
2.2-3.3 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

tant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM),
Evidence 10 Activity

Activity

MIC
Antibacterial
2-35 µM

Target

A. salmonicida

Source & Reference

dbAMP DRAMP

Other

A (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 u
Evidence 11 Activity

Activity

MIC
Antibacterial
4-8 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

(MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtili
Evidence 12 Activity

Activity

MIC
Antibacterial
2.2-4.4 µM

Target

C. aquatilis

Source & Reference

dbAMP DRAMP

Other

ainst E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (
Evidence 13 Activity

Activity

MIC
Antibacterial
4.4-8.8 µM

Target

P. haemolytica

Source & Reference

dbAMP DRAMP

Other

A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (
Evidence 14 Activity

Activity

MIC
Antibacterial
1.1-2.2 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

IC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it
Evidence 15 Activity

Activity

MIC
Antibacterial
17.7-35 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacte
Evidence 16 Activity

Activity

MIC
Antibacterial
8 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP

Other

(MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacteria S. mutans (UA 159, UA 1
Evidence 17 Activity

Activity

MIC
Antibacterial
2-32 µg/mL

Target

L. fermenti

Source & Reference

dbAMP DRAMP

Other

. sanguinis ATCC 10556 S. sobrinus ATCC 6715, S. gordonii ATCC 10558, L. casei ATCC 393, L. fermenti (MIC 2-32 ug/ml) ( Tao R et al., 2011 ). Antibiofilm:bacteria: this peptide disrupted bacterial biofilm:S.
Evidence 18 Activity

Activity

IC50
IC50 = 54.9 µM
Anticancer
54.9 µM

Target

Liver Cancer
J5
Liver

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 19 Activity

Activity

IC50
IC50 = 340.9 µM
Anticancer
340.9 µM

Target

Liver Cancer
Hep3B
Liver

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 20 Activity

Activity

IC50
IC50 = 300.8 µM
Anticancer
300.8 µM

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 21 Activity

Activity

IC50
IC50 = 186.5 µM
Anticancer
186.5 µM

Target

Stomach Cancer
AGS
Stomach

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2022
Evidence 22 Activity

Activity

MIC
Antifungal
2 µM

Target

A. salmonicida 99-1

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I o
Evidence 23 Activity

Activity

MIC
Antifungal
2 µM

Target

A. salmonicida 97-4

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aerugin
Evidence 24 Activity

Activity

MIC
Antifungal
2-17.7 µM

Target

S. enterica serovar Typhimurium MS7953s or 14028s or I or II

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM),
Evidence 25 Activity

Activity

MIC
Antifungal
4-8 µM

Target

Pseudomonas aeruginosa K799 or Z61

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicil
Evidence 26 Activity

Activity

MIC
Antifungal
2-4 µM

Target

Escherichia coli CGSC4908 or UB1005 or DC2

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM),
Evidence 27 Activity

Activity

MIC
Antifungal
8 µM

Target

Staphylococcus epidermidis C621

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

, P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Al
Evidence 28 Activity

Activity

MIC
Antifungal
8 µM

Target

Staphylococcus aureus C623 or MRSA

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonici
Evidence 29 Activity

Activity

MIC
Antifungal
8 µM

Target

Candida albicans C627

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aerugino
Evidence 30 Activity

Activity

MIC
Antifungal
2.2-3.3 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

tant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM),
Evidence 31 Activity

Activity

MIC
Antifungal
2-35 µM

Target

A. salmonicida

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

A (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 u
Evidence 32 Activity

Activity

MIC
Antifungal
4-8 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtili
Evidence 33 Activity

Activity

MIC
Antifungal
2.2-4.4 µM

Target

C. aquatilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ainst E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (
Evidence 34 Activity

Activity

MIC
Antifungal
4.4-8.8 µM

Target

P. haemolytica

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (
Evidence 35 Activity

Activity

MIC
Antifungal
1.1-2.2 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

IC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it
Evidence 36 Activity

Activity

MIC
Antifungal
17.7-35 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacte
Evidence 37 Activity

Activity

MIC
Antifungal
8 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

(MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacteria S. mutans (UA 159, UA 1
Evidence 38 Activity

Activity

MIC
Antifungal
2-32 µg/mL

Target

L. fermenti

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

. sanguinis ATCC 10556 S. sobrinus ATCC 6715, S. gordonii ATCC 10558, L. casei ATCC 393, L. fermenti (MIC 2-32 ug/ml) ( Tao R et al., 2011 ). Antibiofilm:bacteria: this peptide disrupted bacterial biofilm:S.
Evidence 39 Activity

Activity

MIC
Antiparasitic
2 µM

Target

A. salmonicida 99-1

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I o
Evidence 40 Activity

Activity

MIC
Antiparasitic
2 µM

Target

A. salmonicida 97-4

Source & Reference

DRAMP

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aerugin
Evidence 41 Activity

Activity

MIC
Antiparasitic
2-17.7 µM

Target

S. enterica serovar Typhimurium MS7953s or 14028s or I or II

Source & Reference

DRAMP

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM),
Evidence 42 Activity

Activity

MIC
Antiparasitic
4-8 µM

Target

Pseudomonas aeruginosa K799 or Z61

Source & Reference

DRAMP

Other

(MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicil
Evidence 43 Activity

Activity

MIC
Antiparasitic
2-4 µM

Target

Escherichia coli CGSC4908 or UB1005 or DC2

Source & Reference

DRAMP

Other

ium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM),
Evidence 44 Activity

Activity

MIC
Antiparasitic
8 µM

Target

Staphylococcus epidermidis C621

Source & Reference

DRAMP

Other

, P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Al
Evidence 45 Activity

Activity

MIC
Antiparasitic
8 µM

Target

Staphylococcus aureus C623 or MRSA

Source & Reference

DRAMP

Other

4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonici
Evidence 46 Activity

Activity

MIC
Antiparasitic
8 µM

Target

Candida albicans C627

Source & Reference

DRAMP

Other

S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aerugino
Evidence 47 Activity

Activity

MIC
Antiparasitic
2.2-3.3 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

tant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM),
Evidence 48 Activity

Activity

MIC
Antiparasitic
2-35 µM

Target

A. salmonicida

Source & Reference

DRAMP

Other

A (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 u
Evidence 49 Activity

Activity

MIC
Antiparasitic
4-8 µM

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

(MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtili
Evidence 50 Activity

Activity

MIC
Antiparasitic
2.2-4.4 µM

Target

C. aquatilis

Source & Reference

DRAMP

Other

ainst E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (
Evidence 51 Activity

Activity

MIC
Antiparasitic
4.4-8.8 µM

Target

P. haemolytica

Source & Reference

DRAMP

Other

A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (
Evidence 52 Activity

Activity

MIC
Antiparasitic
1.1-2.2 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

IC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it
Evidence 53 Activity

Activity

MIC
Antiparasitic
17.7-35 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacte
Evidence 54 Activity

Activity

MIC
Antiparasitic
8 µM

Target

Staphylococcus epidermidis

Source & Reference

DRAMP

Other

(MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacteria S. mutans (UA 159, UA 1
Evidence 55 Activity

Activity

MIC
Antiparasitic
2-32 µg/mL

Target

L. fermenti

Source & Reference

DRAMP

Other

. sanguinis ATCC 10556 S. sobrinus ATCC 6715, S. gordonii ATCC 10558, L. casei ATCC 393, L. fermenti (MIC 2-32 ug/ml) ( Tao R et al., 2011 ). Antibiofilm:bacteria: this peptide disrupted bacterial biofilm:S.
Evidence 56 Activity

Activity

MIC
Antiviral
2 µM

Target

A. salmonicida 99-1

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I o
Evidence 57 Activity

Activity

MIC
Antiviral
2 µM

Target

A. salmonicida 97-4

Source & Reference

DRAMP

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aerugin
Evidence 58 Activity

Activity

MIC
Antiviral
2-17.7 µM

Target

S. enterica serovar Typhimurium MS7953s or 14028s or I or II

Source & Reference

DRAMP

Other

Highly active against A. salmonicida 99-1 (MIC 2 uM), A. salmonicida 97-4 (MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM),
Evidence 59 Activity

Activity

MIC
Antiviral
4-8 µM

Target

Pseudomonas aeruginosa K799 or Z61

Source & Reference

DRAMP

Other

(MIC 2 uM), S. enterica serovar Typhimurium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicil
Evidence 60 Activity

Activity

MIC
Antiviral
2-4 µM

Target

Escherichia coli CGSC4908 or UB1005 or DC2

Source & Reference

DRAMP

Other

ium MS7953s or 14028s or I or II (MIC 2-17.7 uM), P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM),
Evidence 61 Activity

Activity

MIC
Antiviral
8 µM

Target

Staphylococcus epidermidis C621

Source & Reference

DRAMP

Other

, P. aeruginosa K799 or Z61 (MIC 4-8 uM), E. coli CGSC4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Al
Evidence 62 Activity

Activity

MIC
Antiviral
8 µM

Target

Staphylococcus aureus C623 or MRSA

Source & Reference

DRAMP

Other

4908 or UB1005 or DC2 (MIC 2-4 uM), S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonici
Evidence 63 Activity

Activity

MIC
Antiviral
8 µM

Target

Candida albicans C627

Source & Reference

DRAMP

Other

S. epidermidis C621 (MIC 8 uM), methicillin-resistant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aerugino
Evidence 64 Activity

Activity

MIC
Antiviral
2.2-3.3 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

tant S. aureus C623 or MRSA (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM),
Evidence 65 Activity

Activity

MIC
Antiviral
2-35 µM

Target

A. salmonicida

Source & Reference

DRAMP

Other

A (MIC 8 uM), C. albicans C627 (MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 u
Evidence 66 Activity

Activity

MIC
Antiviral
4-8 µM

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

(MIC 8 uM). Also, active against E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtili
Evidence 67 Activity

Activity

MIC
Antiviral
2.2-4.4 µM

Target

C. aquatilis

Source & Reference

DRAMP

Other

ainst E. coli (MIC 2.2-3.3 uM), A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (
Evidence 68 Activity

Activity

MIC
Antiviral
4.4-8.8 µM

Target

P. haemolytica

Source & Reference

DRAMP

Other

A. salmonicida (MIC 2-35 uM), P. aeruginosa (MIC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (
Evidence 69 Activity

Activity

MIC
Antiviral
1.1-2.2 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

IC 4-8 uM) C. aquatilis (MIC 2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it
Evidence 70 Activity

Activity

MIC
Antiviral
17.7-35 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

2.2-4.4 uM), P. haemolytica (MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacte
Evidence 71 Activity

Activity

MIC
Antiviral
8 µM

Target

Staphylococcus epidermidis

Source & Reference

DRAMP

Other

(MIC 4.4-8.8 uM), Gram-positive B. subtilis (MIC 1.1-2.2 uM), S. aureus (MIC 17.7-35 uM), S. epidermidis (MIC 8 uM), and C. albicans. In addition, it is active against oral bacteria S. mutans (UA 159, UA 1
Evidence 72 Activity

Activity

MIC
Antiviral
2-32 µg/mL

Target

L. fermenti

Source & Reference

DRAMP

Other

. sanguinis ATCC 10556 S. sobrinus ATCC 6715, S. gordonii ATCC 10558, L. casei ATCC 393, L. fermenti (MIC 2-32 ug/ml) ( Tao R et al., 2011 ). Antibiofilm:bacteria: this peptide disrupted bacterial biofilm:S.
Evidence 73 Activity

Activity

<5% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
<5% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. | Int J Antimicrob Agents | 2008
Evidence 74 Activity

Activity

6% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
6% Hemolysis | 100 | µM | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Interaction of pleurocidin and its analogs with phospholipid membrane and their antibacterial activity. | J Pept Res | 2001
Evidence 75 Activity

Activity

50% Cell death
Toxicity
350 µM
Cytotoxic
50% Cell death | 350 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy. | Mol Cell Biochem | 2015
Evidence 76 Activity

Activity

0% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
0% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structure-antimicrobial activity relationship between pleurocidin and its enantiomer. | Exp Mol Med | 2008
Evidence 77 Activity

Activity

29% Hemolysis
Toxicity
50 µM
Hemolytic Cytotoxic
29% Hemolysis | 50 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structure-antimicrobial activity relationship between pleurocidin and its enantiomer. | Exp Mol Med | 2008
Evidence 78 Activity

Activity

77% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
77% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structure-antimicrobial activity relationship between pleurocidin and its enantiomer. | Exp Mol Med | 2008
Evidence 79 Activity

Activity

50% Cell death
Toxicity
56 µM
Cytotoxic
50% Cell death | 56 | µM | target cell: Mouse fibroblasts NIH 3T3

Target

Mouse fibroblasts NIH 3T3

Source & Reference

NA
DBAASP
Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy. | Mol Cell Biochem | 2015
Evidence 80 Activity

Activity

7% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
7% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Influence of the hydrophobic amino acids in the N- and C-terminal regions of pleurocidin on antifungal activity. | J Microbiol Biotechnol | 2010
Evidence 81 Activity

Activity

50% Hemolysis
Toxicity
>256 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. | Dis Model Mech | 2011
Evidence 82 Activity

Activity

100% Killing
Toxicity
5 µM
Cytotoxic
100% Killing | 5 | µM | target cell: Zebrafish embryos

Target

Zebrafish embryos

Source & Reference

NA
DBAASP
The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. | Dis Model Mech | 2011
Evidence 83 Activity

Activity

>10% Killing
Toxicity
5 µM
Cytotoxic
>10% Killing | 5 | µM | target cell: Zebrafish embryos

Target

Zebrafish embryos

Source & Reference

NA
DBAASP
The zebrafish embryo as a tool for screening and characterizing pleurocidin host-defense peptides as anti-cancer agents. | Dis Model Mech | 2011
Evidence 84 Activity

Activity

3% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
3% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytes. | Int J Antimicrob Agents | 2011
Evidence 85 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.